- Report
- January 2026
- 187 Pages
Global
From €3216EUR$3,545USD£2,772GBP
€3574EUR$3,939USD£3,080GBP
- Report
- February 2026
- 160 Pages
Global
From €3765EUR$4,150USD£3,245GBP
- Report
- January 2026
- 187 Pages
Global
From €3216EUR$3,545USD£2,772GBP
€3574EUR$3,939USD£3,080GBP
- Report
- February 2026
- 250 Pages
Global
From €4073EUR$4,490USD£3,511GBP
- Report
- February 2026
- 250 Pages
Global
From €4073EUR$4,490USD£3,511GBP
- Report
- October 2025
- 160 Pages
Global
From €3584EUR$3,950USD£3,088GBP
- Report
- July 2024
- 100 Pages
Global
From €3402EUR$3,750USD£2,932GBP
- Report
- December 2023
- 1362 Pages
Global
From €9068EUR$9,995USD£7,815GBP
- Report
- May 2023
- 117 Pages
Global
From €3500EUR$4,133USD£3,122GBP
- Report
- May 2023
- 81 Pages
Global
From €3500EUR$4,133USD£3,122GBP
The Patent Foramen Ovale (PFO) Device market is a subset of the Cardiovascular Devices market. It is composed of medical devices used to close a hole in the heart, known as a patent foramen ovale (PFO). This hole is a natural opening between the two upper chambers of the heart, and it is present in about 25% of the population. PFO closure devices are used to reduce the risk of stroke and other neurological events. These devices are typically implanted during a minimally invasive procedure, and they are designed to remain in place for the lifetime of the patient.
The PFO Device market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Abbott, Boston Scientific, W.L. Gore & Associates, and Occlutech. Show Less Read more